Virtus Biotech ETF (BBP) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores BBP 5.9 out of 10 — highest on Growth (9.9), lowest on Quality (0.3). Its ten largest holdings are 27% of the fund.
What stands out in BBP's data
Biotech and health-care stocks, picked through a focused index.
Its three-year run beats most peers — a stretch of strong performance in a tough sector.
Returned 29% annualized over three years, ahead of most peers and well above the category median of 17%. Pays no dividend.
A niche sleeve for portfolios that want targeted biotech exposure.
Why did BBP move this week? It rose 2.2% in the week to October 9, 2026 — Moderna and Novavax drove it
BBP rose 2.2% in the week to October 9, 2026. The holdings that moved it most were Moderna (+18.4%), Novavax (+21.9%) and Xeris Biopharma (+15.4%); Precigen (−8.5%) pushed the other way.
How is BBP rated? ETF Copilot scores Virtus Biotech ETF (BBP) 5.9 out of 10
As of October 9, 2026, ETF Copilot scores Virtus Biotech ETF (BBP) 5.9 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 5.9 / 10
- Growth: 9.9 / 10
- Risk: 2.0 / 10
- Quality: 0.3 / 10
- Return: 8.3 / 10
What's inside BBP?
What's inside BBP: Size (Large 16%, Mid 40%, Small 44%); Geography (International 15%, US 85%).
What are BBP's top holdings? The ten largest are 27% of the fund
Moderna, Iovance Biotherapeutics, Omeros, Verastem, Precigen, Halozyme Therapeutics, Kiniksa Pharmaceuticals International, Xeris Biopharma, ZAI LAB and Rigel Pharmaceuticals are BBP's largest holdings, in that order.
Less concentrated than 75% of Health & Biotech ETFs.
Half of BBP's weight sits in its 25 largest positions, and once those weights are taken into account it behaves like 54 equally weighted holdings.
What is BBP's expense ratio? 0.34% a year
As of October 9, 2026, BBP charges 0.34% a year and holds $127M in assets across 65 positions.
| Measure | BBP |
|---|---|
| Expense ratio | 0.34% |
| Assets under management | $127M |
| Holdings | 65 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Virtus Biotech ETF (BBP) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/bbp
ETF Copilot Pro unlocks BBP's price and what each holding weighs.
Try Pro free →